Preparation of water-soluble chitosan/heparin complex and its application as wound healing accelerator

被引:189
作者
Kweon, DK
Song, SB
Park, YY
机构
[1] Natl Inst Adv Ind Sci & Technol, Special Div Human Life Technol, Green Biotechnol Res Grp, Ikeda, Osaka 5638577, Japan
[2] Hansbiomed Co Ltd, Daeduk Res Inst, Yuseong Ku, Taejon 305811, South Korea
[3] Hanyang Univ, Coll Med, Dept Pathol, Guri Si 471701, Kyungi Do, South Korea
关键词
water-soluble chitosan/heparin complex; wound healing ability; histological examination; skin appendage;
D O I
10.1016/S0142-9612(02)00566-5
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To make effective wound healing accelerator, water-soluble chitosan (WSC)/heparin (CH) complex was prepared using WSC with wound healing ability and heparin with ability to attract or bind growth factor related to wound healing process. Water-soluble CH complex was prepared by the reaction between WSC and heparin, and then, by adding distilled water to it, ointment type with high viscosity was made. To evaluate the wound healing effect, full thickness skin excision was performed on the backs of the rat and then WSC and water-soluble CH complex ointments were applied in the wounds, respectively. After 15 days, gross and histologic examination was performed. Grossly, untreated control group revealed that the wound had well defined margin and was covered by crust. The second group treated with WSC ointment revealed small wound size with less amount of covering crust and ill-defined margin, which appeared to regenerate from margin. The third group treated with water-soluble CH complex ointment appeared to be nearly completely healed. Histology of each group was well correlated to gross findings. The third group shows nearly complete regeneration of appendage structure similar to normal in the dermis in contrast to control and second group with absence and less number of skin appendages, respectively. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1595 / 1601
页数:7
相关论文
共 29 条
[1]   Heparan mimetic regulates collagen expression and TGF-β1 distribution in gamma-irradiated human intestinal smooth muscle cells [J].
Alexakis, C ;
Guettoufi, A ;
Mestries, P ;
Strup, C ;
Mathe, D ;
Barbaud, C ;
Barritault, D ;
Caruelle, JP ;
Kern, P .
FASEB JOURNAL, 2001, 15 (09) :1546-1554
[2]   ENHANCEMENT OF WOUND-HEALING BY TOPICAL TREATMENT WITH EPIDERMAL GROWTH-FACTOR [J].
BROWN, GL ;
NANNEY, LB ;
GRIFFEN, J ;
CRAMER, AB ;
YANCEY, JM ;
CURTSINGER, LJ ;
HOLTZIN, L ;
SCHULTZ, GS ;
JURKIEWICZ, MJ ;
LYNCH, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (02) :76-79
[3]   STRUCTURE AND BIOLOGICAL-ACTIVITY OF HEPARIN [J].
CASU, B .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1985, 43 :51-134
[4]   ANTIPROLIFERATIVE EFFECTS OF HEPARIN ON NORMAL AND TRANSFORMED NIH 3T3 FIBROBLASTS [J].
CAVARI, S ;
RUGGIERO, M ;
VANNUCCHI, S .
CELL BIOLOGY INTERNATIONAL, 1993, 17 (08) :781-786
[5]   EGF receptors of hepatocytes from rats treated with phenobarbital are sensitized to down-regulation by phenobarbital in culture [J].
Dalton, SR ;
Jirtle, RL ;
Meyer, SA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 165 (02) :115-126
[6]   HUMAN ARTERIAL SMOOTH-MUSCLE CELLS IN CULTURE - EFFECTS OF PLATELET-DERIVED GROWTH-FACTOR AND HEPARIN ON GROWTH-INVITRO [J].
FAGER, G ;
HANSSON, GK ;
OTTOSSON, P ;
DAHLLOF, B ;
BONDJERS, G .
EXPERIMENTAL CELL RESEARCH, 1988, 176 (02) :319-335
[7]  
FLINT N, 1994, J CELL SCI, V107, P401
[8]   HEPARIN PROTECTS BASIC AND ACIDIC FGF FROM INACTIVATION [J].
GOSPODAROWICZ, D ;
CHENG, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 128 (03) :475-484
[9]   The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro [J].
Howling, GI ;
Dettmar, PW ;
Goddard, PA ;
Hampson, FC ;
Dornish, M ;
Wood, EJ .
BIOMATERIALS, 2001, 22 (22) :2959-2966
[10]  
KIFUNE K, 1992, ADVANCES IN CHITIN AND CHITOSAN, P9